These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 79659)

  • 1. Alloantisera reacting with tumor cells of inappropriate haplotype. I. Characterization of target antigens.
    Prat M; Rogers MJ; Appella E
    J Natl Cancer Inst; 1978 Aug; 61(2):527-34. PubMed ID: 79659
    [No Abstract]   [Full Text] [Related]  

  • 2. The Tla locus: a new allele and antigenic specificity.
    Flaherty L; Sullivan K; Zimmerman D
    J Immunol; 1977 Aug; 119(2):571-5. PubMed ID: 69663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anomalous reactions of mouse alloantisera with cultured tumor cells. I. Demonstration of widespread occurrence using reference typing sera.
    Klein PA
    J Immunol; 1975 Nov; 115(5):1254-60. PubMed ID: 51886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. II. Increased expression of tumor-associated antigens on subline cells recognized by serologic and transplantation methods.
    Fuji H; Mihich E; Pressman D
    J Natl Cancer Inst; 1979 Jun; 62(6):1503-10. PubMed ID: 286122
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of cytolytic T lymphocyte clones reactive with Moloney leukemia virus-associated antigens by monoclonal antibodies: a direct approach to the study of H-2 restriction.
    Weiss A; MacDonald HR; Cerottini JC; Brunner KT
    J Immunol; 1981 Feb; 126(2):482-5. PubMed ID: 6450244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Humoral autoimmune reactions directed against autoantigens of the H-2 histocompatibility system in mice with developing Rauscher leukemia].
    Ter-Griggorov VS; Moskovkina OIa; Krupnik VE; Graf IA; Pivnik AV
    Eksp Onkol; 1988; 10(6):21-5. PubMed ID: 2468468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
    Green WR
    J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of antigens on murine tumor cells reacting with alloantisera against foreign H-2 specificities: analysis by absorption with purified murine leukemia virus and normal lymphoid cells of different H-2 haplotypes.
    Schirrmacher V; Marxen I; Robinson P
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):155-68. PubMed ID: 85374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of antileukemia sera prepared by immunization with leukemia cells admixed with normal antigen-blocking sera.
    Smith PJ; Robinson CM; Reif AE
    Cancer Res; 1974 Jan; 34(1):169-75. PubMed ID: 4129197
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated membrane antigens and the antitumor immune reactions.
    Levy JP; Kourilsky FM
    Transplant Proc; 1973 Dec; 5(4):1435-40. PubMed ID: 4130056
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line.
    Saxena RK; Adler WH
    J Immunol; 1979 Aug; 123(2):846-51. PubMed ID: 110883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target sites for antibodies and cytotoxic T lymphocytes on H-2 molecules.
    Rüsch E; Kuon W; Hämmerling GJ
    Transplant Proc; 1983 Dec; 15(4):2093-6. PubMed ID: 6200977
    [No Abstract]   [Full Text] [Related]  

  • 15. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
    J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunologic paralysis during tumor growth].
    Shats VIa
    Vopr Onkol; 1974; 20(11):85-95. PubMed ID: 4612973
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice.
    Martin WJ; Wunderlich JR; Macdonald J
    Isr J Med Sci; 1973 Mar; 9(3):324-31. PubMed ID: 4710040
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the possibility of induction of anti-H-2 alloreactive cytotoxic antibodies by syngeneic immunization.
    Opolski A; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):621-30. PubMed ID: 6085470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Participation of soluble H-2 antigens in serological and cellular reactions].
    Pletneva TP; Kaulen DR; Khorobrykh VV; Kirkin AF; Kotomina IF
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1979; (5):24-8. PubMed ID: 88233
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.
    Ozato K; Sachs DH
    J Immunol; 1981 Jan; 126(1):317-21. PubMed ID: 6935293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.